Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2003
03/27/2003US20030060479 Compositions and medical device for transdermal delivery of a drug and methods of making and using same
03/27/2003US20030060451 Such as cephalosporin beta-lactam antibiotic (cefditoren pivoxil); drug delivery
03/27/2003US20030060447 Non-aspirating transitional viscoelastics for use in surgery
03/27/2003US20030060427 Dissolving an organic compound having a lactone nucleus in lower alcohol and water; antitumor agents
03/27/2003US20030060421 Kits and compositions supporting intracranial perfusions
03/27/2003US20030060414 Preventing bovine mastitis by injecting a sterilising agent bacteriocin into the teat and subsequently delivering the sealant into the teat
03/27/2003US20030060404 Storage stability, long shelf life; a solution has anti-microbial activity without additional anti-microbial agent; growth hormones for cats and dogs; veterinary medicine
03/27/2003US20030060402 Novel cyclosporin galenic forms
03/27/2003US20030060381 Dispersion comprising a non-ionic emulsifier
03/27/2003US20030059906 Block copolymers for multifunctional self-assembled systems
03/27/2003US20030059773 Immunomodulatory formulations and methods for use thereof
03/27/2003US20030059614 Enrobed core medicament
03/27/2003US20030059489 Genital lubricating compositions and uses thereof
03/27/2003US20030059475 Fibrin microbeads and uses thereof
03/27/2003US20030059474 Sustained release microspheres
03/27/2003US20030059473 Method for preparing colloidal particles in the form of nanocapsules
03/27/2003US20030059472 Preparation of submicron sized nanoparticles via dispersion lyophilization
03/27/2003US20030059471 Oral delivery formulation
03/27/2003US20030059470 Dispersions for the formulation of slightly or poorly soluble agents
03/27/2003US20030059469 Protecting the carboxylic acid group of the drug molecule, adding to the drug molecule a chlorinated polyanhydride linker, deprotecting by exposing the linked drug molecules to heat or vacuum, acetylating to produce monomer, polymerizing
03/27/2003US20030059468 Preparations and processes for stabilizing biological materials by means of drying processes without freezing
03/27/2003US20030059467 A tablet core containing from 0.5 to 10% of doxazosin and 20 to 95% by weight of polyethylene oxide forming a hydrohilic matrix, and core being obtained by compressing granules
03/27/2003US20030059466 Delayed release tablet of venlafaxin
03/27/2003US20030059465 Stabilized nanoparticle formulations of camptotheca derivatives
03/27/2003US20030059462 Dissolving a powder of liposome-forming lipids in an organic solvent to a level close to saturation, adding to the solute obtained a dry, water immiscible carotenoid to obtain a suspension, drying and dehydrating the powder obtained
03/27/2003US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets
03/27/2003US20030059458 Encapsulated carob fibers having improved product properties, process for production thereof and use thereof
03/27/2003US20030059456 Intravaginal drug delivery devices for the administration of an antimicrobial agent
03/27/2003US20030059455 A defective recombinant adenovirus including at least one DNA sequence coding for all or an active part of a superoxide; useful for treating and/or preventing Parkinson's disease, Alzheimer's disease, Huntington's disease etc.
03/27/2003US20030059452 Cosmetic composition comprising at least non-polymeric crystalline salt
03/27/2003US20030059450 Anti-aging formulation containing a cosmeceutically active base, which is a hydroxide- releasing inorganic or nitrogen containing organic base, the formulation has a pH in the range of about 7.5 to 13.0
03/27/2003US20030059449 Concentrated stock of capsules for detergent or personal care compositions
03/27/2003US20030059446 Physically stable sprayable gel composition
03/27/2003US20030059440 Composition and method for moisturizing nasal tissue
03/27/2003US20030059435 Stable compressed or hard tableted vaccine composition comprising at least one lyophilized antigenic component and a dissolution aid
03/27/2003US20030059402 Aquespheres, their preparation and uses thereof
03/27/2003US20030059398 Water-soluble stabilized self-assembled polyelectrolytes
03/27/2003US20030059394 Foam skin cream, uses of the foam skin protection cream and a process for its preparation
03/27/2003US20030059381 Packaged product for use with tooth whitening systems that is storage stable in absence of light
03/27/2003US20030059380 Inhomogeneous silicas as carrier material
03/27/2003US20030059376 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
03/27/2003US20030059375 Method for treating lung cancers
03/27/2003US20030059374 Use of metoclopramide
03/27/2003US20030059371 Compositions injectable via a catheter to form occlusive masses in a selected body region; highly dispersed in a liquid medium of given specific gravity; nonclumping in the delivery equipment during embolization
03/27/2003US20030056896 Controlled release formulation to be administered by osmosis, diffusion, erosion, or ion exchange
03/27/2003US20030056788 Partial liquid breathing of fluorocarbons
03/27/2003DE20219658U1 Composition for reducing body weight, contains swellable compound, preferably polysaccharide, to give satiation effect and nutrients and/or active agents for retarded release
03/27/2003CA2460985A1 Nestin-expressing hair follicle stem cells
03/27/2003CA2460885A1 Composition comprising cysteamine for improving lactation in dairy animals
03/27/2003CA2460783A1 Bioprecursors for percutaneous application
03/27/2003CA2460460A1 Fermentation product of cryptoporus volvatus and its preparation method and use
03/27/2003CA2460360A1 Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
03/27/2003CA2460334A1 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2003CA2460076A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
03/27/2003CA2458720A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatment
03/27/2003CA2458272A1 Microtubes for therapeutic delivery
03/26/2003EP1295611A1 Oligonucleotide-transferring preparations
03/26/2003EP1295602A1 Oxygen-containing ophthalmic composition
03/26/2003EP1295601A1 Pharmaceutical composition based on a non-steroid anti-inflammatory agent
03/26/2003EP1295598A1 Pharmaceutical composition containing two active ingredients for smoking cessation
03/26/2003EP1295596A1 Systems and compounds for drug delivery to interstitial regions of the myocardium
03/26/2003EP1295595A1 Tablet rapidly disintegrating in mouth and process for producing the same
03/26/2003EP1295538A2 Encapsulated locust bean fibre with improved properties, process for making it and use thereof
03/26/2003EP1294808A2 Fast cure film forming formulation
03/26/2003EP1294802A1 Polysaccharide based gel
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294742A2 Urokinase inhibitors
03/26/2003EP1294717A2 A thiazine oxazolidinone
03/26/2003EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
03/26/2003EP1294646A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
03/26/2003EP1294479A1 Method for producing capsules containing an active ingredient and having an ultra-thin coating
03/26/2003EP1294439A2 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system
03/26/2003EP1294413A1 Sprayable wound care compositions
03/26/2003EP1294412A1 Method of using lectins for contraception and prophylaxis agains t diseases transmittable by sexual contact and condom containing lectins
03/26/2003EP1294411A1 A novel treatment for cough
03/26/2003EP1294400A1 Vaccine against foot-and-mouth disease
03/26/2003EP1294399A2 Methods and composition for oral vaccination
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294380A1 A method for treating septic shock
03/26/2003EP1294376A2 Medicament for combating respiratory depression
03/26/2003EP1294375A2 Method of treatment of seborrheic dermatitis
03/26/2003EP1294373A1 Pharmaceutical disinfectants comprising usnic acid and essential oils
03/26/2003EP1294372A2 Dry powder formulation comprising racecadotril
03/26/2003EP1294369A1 NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE
03/26/2003EP1294368A1 Management of snoring by oral administration of dimethyl sulfone
03/26/2003EP1294367A2 Oral compositions comprising host-response modulating agent
03/26/2003EP1294365A2 Cytotoxic agents comprising single-stranded and/or looped dna
03/26/2003EP1294364A1 Stable gabapentin having ph within a controlled range
03/26/2003EP1294363A1 Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1294361A2 Compositions and methods to improve the oral absorption of antimicrobial agents
03/26/2003EP1294360A1 Novel process for preparing and harvesting crystalline particles
03/26/2003EP1294359A1 Process for preparing and harvesting crystalline particles
03/26/2003EP1294358A2 Wet milling process
03/26/2003EP1294357A1 Bioavailable dosage form of isotretinoin
03/26/2003EP1294356A2 Sustained release delivery systems for solutes
03/26/2003EP1294352A1 Cosmetic treatment and device
03/26/2003EP1294346A2 Structures and compositions increasing stability peroxide actives stability
03/26/2003EP1294325A1 Combination sis and vacuum bandage and method
03/26/2003EP1225810B1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves
1 ... 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 ... 2991